Pharmacists in Indian Trail, North Carolina


28 Pharmacists found in Indian Trail
male pharmacist

Mr. Kevin Paul Pultorak, RPH


Pharmacist
6610 Old Monroe Rd, Indian Trail, NC 28079
704-289-1193     704-289-1662

female pharmacist

Martha S Cholewinski, PHARM D


Pharmacist
13720 Highway 74, Indian Trail, NC 28079
704-821-1589     704-821-1645

male pharmacist

Mr. Miguel A Bejarano, BS RPH


Pharmacist
2101 Younts Rd, Indian Trail, NC 28079
704-882-6853     704-882-7842



female pharmacist

Paula London


Pharmacist
2101 Younts Rd, Indian Trail, NC 28079
704-882-6853     704-882-7842

male pharmacist

Mr. Sam Beegle, RPH


Pharmacist
13720 Highway 74, Indian Trail, NC 28079
704-821-1589    

female pharmacist

Shanice Hicklen


Pharmacist
2101 Younts Rd, Indian Trail, NC 28079
704-882-6853    

female pharmacist

Dr. Shannon N Moore, PHARMD


Pharmacist
4300 Old Monroe Rd, Indian Trail, NC 28079
704-821-6551     704-821-6583

female pharmacist

Shelli Swail, RPH


Pharmacist
13720 Highway 74, Indian Trail, NC 28079
704-821-1589     704-821-1645

female pharmacist

Shilpa Patel, RPH


Pharmacist
5007 Hemby Commons Pkwy, Indian Trail, NC 28079
813-817-1358    

female pharmacist

Tammy Lynn Moore


Pharmacist
4300 Old Monroe Rd, Indian Trail, NC 28079
704-821-6551     704-821-5247

male pharmacist

Dr. Terry Alvin Devine Jr., PHARMD.


Pharmacist
106 Indian Trail Rd S, Indian Trail, NC 28079
704-821-7617     704-821-0177

female pharmacist

Wendy Jackson Truesdale, RPH


Pharmacist
13720 Highway 74, Indian Trail, NC 28079
704-821-1589    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.